Dr Robert Levy, Editor-in-Chief of Neuromodulation: Technology at the Neural Interface, and an Executive Board Member of the International Neuromodulation Society (INS), briefly discusses the scientific program for the INS 2017 13th World Congress. The meeting takes place 27 May – 1 June 2017 in Edinburgh, Scotland.
Source: This video was produced by the INS (http://www.neuromodulation.com/ins-congress) and is shared here with permission.
Share this Video
Related Videos In Epilepsy
Pat Penovich, AES 2020 – The Patient Experience With Diazepam Nasal Spray
It was a pleasure to talk to Pat Penovich (Minnesota Epilepsy Group, St. Paul, MN, USA) about the exit survey, of a Phase 3 study, assessing patient experience of using the diazepam nasal spray for seizure clusters. The abstract ‘Examining the Patient Experience With Diazepam Nasal Spray for Seizure Clusters: Patient-reported Results From an Exit […]
Martin Brodie, CONy 2020 – Combination Antiepileptic Drug Therapy
It was a pleasure to speak with Martin Brodie (President, International Bureau for Epilepsy and co-Section Head of Epilepsy for CONy), who spoke with us on the topic of the debate session he participated in: Should combination antiepileptic drug (AED) therapy be offered immediately after failure of a single antiepileptic drug? Questions Could you tell […]
Ingrid Scheffer, AES 2020 – Long Term Efficacy and Safety of Fenfluramine in Patients with Dravet Syndrome
We were delighted to talk to Ingrid Scheffer (The University of Melbourne, The Royal Children’s Hospital and Austin Health, Victoria, Australia) regarding the open-label extension study of fenfluramine in patients with Dravet syndrome (Clinical Trial Identifier: NCT02823145). The abstract ‘Efficacy and Tolerability of Adjunctive FINTEPLA (Fenfluramine Hydrochloride) in an Open-Label Extension Study of Dravet Syndrome […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!